Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011365 |
---|---|
Receipt number | R000012355 |
Scientific Title | Phase II study of neoadjuvant bevacizumab with weekday-on/weekday-off capecitabine and radiation for locally advanced rectal cancer |
Date of disclosure of the study information | 2013/08/03 |
Last modified on | 2016/08/05 09:31:51 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/08/03 15:21:32 | ||
2 | Update | 2014/02/04 09:10:35 | Email |
|
3 | Update | 2016/08/05 09:31:51 | Name of primary person or sponsor Organization |